Author: Enoki, Yuki; Igarashi, Yuki; Watabe, Yuki; Honma, Kyoka; Suzuki, Yuto; Hayashi, Yukitaka; Hiraoka, Kana; Taguchi, Kazuaki; Matsumoto, Kazuaki
Title: Remdesivir for the treatment of coronavirus COVID-19: A meta-analysis of randomised controlled trials Cord-id: 783xcdkd Document date: 2020_12_8
ID: 783xcdkd
Snippet: • Remdesivir is proposed as a therapeutic for COVID-19; • Clinical improvement after remdesivir was higher compared with placebo; • Remdesivir tended to reduce patient mortality rate, but this was not significant.
Document: • Remdesivir is proposed as a therapeutic for COVID-19; • Clinical improvement after remdesivir was higher compared with placebo; • Remdesivir tended to reduce patient mortality rate, but this was not significant.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date